BioLineRx

BioLineRx is a clinical-stage biopharmaceutical development company, focuses on oncology. Its development pipeline consists of clinical-stage therapeutic candidates. BioLineRx was founded in 2003 and is headquartered in Modi'in, Israel.
BioLineRx stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

BioLineRx balance sheet

Report period2016 2017 2018 2019 2020 2021
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

BioLineRx cash flows

Report period2016 2017 2018 2019 2020 2021
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Adjusted EBITDA
OIBDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

BioLineRx multipliers

Report period2016 2017 2018 2019 2020 2021
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

BioLineRx profitability

Report period2016 2017 2018 2019 2020 2021
ROA
ROE
ROS
BioLineRx assets
BioLineRx cash flows

BioLineRx dividend policy

The company doesn't provide dividend

BioLineRx shares

TickerNameTypeNominal valueISINPrice
BLRX:USBioLineRx Common share-US09071M2052$0.5469
BioLineRx news
11.05.2022
BioLineRx's IFRS loss for 3 months of 2022 was $4.93 million, down 2.07 times from $10.192 million in the previous year.
Source: ir.biolinerx.com pictogram ir.biolinerx.com
Pictogram next
16.03.2022
BioLineRx's IFRS loss for 2021 was $27.054 million, down 9.9 percent from $30.021 million in the previous year.
Source: ir.biolinerx.com pictogram ir.biolinerx.com
Pictogram next
18.11.2021
BioLineRx's IFRS loss for 9M 2021 was $22.75 million, up 26.2% from $18.033 million in the prior year.
Source: ir.biolinerx.com pictogram ir.biolinerx.com
Pictogram next
18.08.2021
BioLineRx' IFRS loss for 6M 2021 was $17.034 million, up 27% from $13.415 million in the previous year.
Source: ir.biolinerx.com pictogram ir.biolinerx.com
Pictogram next
All BioLineRx news
General information
Company nameBioLineRx
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business addressModi’in Technology Park 2 HaMa’ayan Street Hevel Modi'in 7177871 Israel
Mailing addressModi’in Technology Park 2 HaMa’ayan Street Hevel Modi'in 7177871 Israel
Websiteir.biolinerx.com
Information disclosurewww.sec.gov